Adaptimmune Therapeutics (ADAP) Stock Chart & Stock Price History $0.27 +0.01 (+3.04%) As of 03:54 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Adaptimmune Therapeutics Stock Price Performance 5 Day Performance+12.55%1 Month Performance-3.14%3 Month Performance-54.71%6 Month Performance-64.25%Year-To-Date Performance-50.23%1 Year Performance-75.18% Receive ADAP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ADAP Stock Chart for Thursday, April, 24, 2025 ADAP Chart by TradingView Adaptimmune Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025$0.26$0.26-0.80%$0.30$0.26693,788 shs$66.93 million04/22/2025$0.24$0.26+8.30%$0.27$0.241.03 million shs$67.47 million04/21/2025$0.24$0.24+1.68%$0.25$0.24488,404 shs$62.30 million04/18/2025$0.24$0.24$0.25$0.24301,922 shs$61.27 million04/17/2025$0.24$0.24-0.75%$0.25$0.24301,922 shs$61.74 million04/16/2025$0.25$0.24-3.81%$0.26$0.232.93 million shs$61.74 million04/15/2025$0.23$0.25+6.67%$0.25$0.23994,301 shs$64.18 million04/14/2025$0.22$0.23+5.22%$0.24$0.22593,246 shs$60.17 million04/11/2025$0.22$0.22+3.40%$0.24$0.201.54 million shs$57.18 million04/10/2025$0.23$0.22-7.84%$0.24$0.21605,061 shs$55.31 million Get the Latest News and Ratings for ADAP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025$0.23$0.23+3.41%$0.24$0.221.43 million shs$60.01 million04/09/2025$0.23$0.23+3.41%$0.24$0.221.43 million shs$60.01 million04/08/2025$0.26$0.23-12.01%$0.31$0.221.72 million shs$58.03 million04/08/2025$0.26$0.23-12.01%$0.31$0.221.72 million shs$58.03 million04/07/2025$0.26$0.26-0.66%$0.28$0.251.21 million shs$65.95 million04/04/2025$0.32$0.26-20.31%$0.32$0.252.01 million shs$66.39 million04/03/2025$0.31$0.32+6.20%$0.33$0.273.91 million shs$83.32 million04/02/2025$0.25$0.31+22.00%$0.32$0.246.75 million shs$78.46 million04/01/2025$0.20$0.25+26.90%$0.25$0.205.89 million shs$63.97 million03/31/2025$0.21$0.20-4.37%$0.21$0.202.89 million shs$50.41 million03/28/2025$0.22$0.21-6.36%$0.24$0.202.96 million shs$52.71 million03/27/2025$0.23$0.22-4.39%$0.24$0.221.88 million shs$56.29 million03/26/2025$0.25$0.23-7.96%$0.26$0.223.16 million shs$58.88 million03/25/2025$0.28$0.25-9.68%$0.29$0.253.08 million shs$63.97 million03/24/2025$0.29$0.28-4.81%$0.31$0.272.89 million shs$70.83 million Related Companies CMPX Stock Price Chart AVIR Stock Price Chart TERN Stock Price Chart ACB Stock Price Chart SLDB Stock Price Chart ATXS Stock Price Chart SLRN Stock Price Chart CDTX Stock Price Chart HUMA Stock Price Chart DRUG Stock Price Chart Receive ADAP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADAP) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptimmune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADAP Stock Free ADAP Stock Alerts